3rd Annual Pharma Pricing, Reimbursement

3rd Annual Pharma Pricing, Reimbursement

Oct 29 9:00am - Oct 30 5:30pm @ Washington, D. C.
Conference
3rd Annual Pharma Pricing, Reimbursement & Market Access 2019 will provide an overview of global pricing, market access systems and cost management techniques, as well as in-depth discussion of some of the most current trends and changes. This Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.
WHO SHOULD ATTEND:
Senior Vice Presidents, Vice Presidents, Senior Executives, Global Heads, Heads, Directors, Senior Managers, Managers of
Pricing, Reimbursement, Market Access, Commercial Pricing, Pricing Strategists, Health Economics, Outcomes Research, Regulatory Affairs, Governmental Affairs, Public Affairs, Public Policy Directors, Operations, Governmental bodies, Regulatory bodies.
KEY SPEAKERS:
• ROBERT POPOVIAN, SR. Director, US Government Relations, Pfizer
• SHANTHY KRISHNARAJAH, Senior Director, Global Health Economics & Reimbursement Strategy, CSL Behring
• BEHZAD MADHAVI, ...
3rd Annual Pharma Pricing, Reimbursement & Market Access 2019 will provide an overview of global pricing, market access systems and cost management techniques, as well as in-depth discussion of some of the most current trends and changes. This Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.
WHO SHOULD ATTEND:
Senior Vice Presidents, Vice Presidents, Senior Executives, Global Heads, Heads, Directors, Senior Managers, Managers of
Pricing, Reimbursement, Market Access, Commercial Pricing, Pricing Strategists, Health Economics, Outcomes Research, Regulatory Affairs, Governmental Affairs, Public Affairs, Public Policy Directors, Operations, Governmental bodies, Regulatory bodies.
KEY SPEAKERS:
• ROBERT POPOVIAN, SR. Director, US Government Relations, Pfizer
• SHANTHY KRISHNARAJAH, Senior Director, Global Health Economics & Reimbursement Strategy, CSL Behring
• BEHZAD MADHAVI, VP Strategic Innovation & Alliances, Lonza
• JENNIFER WONG, Senior Director, Real World Evidence Strategy & Alliances, AstraZeneca
• MARTIN ROST, Senior Director, Market Access (Global), Pfizer
• KRISTINA HARTER, Director, New Product Planning, Boston Pharmaceuticals
• MATTHEW HURLBURT, Global Access Transformation Lead, Pfizer
• RICHARD LINER, Senior Compliance Counsel, Bayer
• ALEEN HOSDAGHIAN, Sr. Director of Marketing, Sun Pharma
• GARY ELLEXSON, VP Corporate Accounts, Supernus Pharmaceuticals
• BOXIONG TANG, Sr. Director, BeiGene
• HEATHER LEIGH FLANNERY, Global Lead, ConsenSys Health
• MICHAEL THOMPSON, President & CEO, National Alliance of Healthcare Purchaser Coalitions
• SUSAN THORNTON, CEO, Cutaneous Lymphoma Foundation
• EVERETT CROSLAND, VP of Market Access & Reimbursement, AppliedVR
• MELVA COVINGTON, Senior Director, EVERSANA, Health Economics and Outcomes Research
• REED STEPHENS, Partner-In-Charge Washington, D.C. Health Industry Advisory Group, McDermott Will & Emery
More information
Organizers